Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | PRNP | P04156 | 1/20 | 0.42 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.39 |
| ▸ | MPO | P05164 | 1/20 | 0.39 |
| ▸ | CYP24A1 | Q07973 | 2/20 | 0.39 |
| ▸ | METAP1 | P53582 | 2/20 | 0.38 |
| ▸ | MIF | P14174 | 3/20 | 0.37 |
| ▸ | CYP27A1 | Q02318 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.36 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4859451 | 0.90 | METAP1 (0.40) | SMN1; SMN2PRNPMPOCYP24A1METAP1 | |
| SCHEMBL629836 | 0.90 | SMN1; SMN2 (0.53) | SMN1; SMN2PRNPDGAT1MPOCYP24A1 | |
| SCHEMBL4853241 | 0.89 | SMN1; SMN2 (0.50) | SMN1; SMN2PRNPDGAT1MPOCYP24A1 | |
| SCHEMBL4857128 | 0.82 | SMN1; SMN2 (0.52) | SMN1; SMN2PRNPDGAT1MPOCYP24A1 | |
| SCHEMBL13477035 | 0.82 | SMN1; SMN2 (0.48) | SMN1; SMN2PRNPDGAT1MPOCYP24A1 | |
| SCHEMBL4860616 | 0.81 | SMN1; SMN2 (0.51) | SMN1; SMN2PRNPDGAT1MPOCYP24A1 | |
| SCHEMBL6860603 | 0.81 | METAP1 (0.47) | SMN1; SMN2PRNPMPOMETAP1MIF | |
| SCHEMBL9341449 | 0.80 | METAP1 (0.43) | SMN1; SMN2METAP1ESR2ALDH1A1LMNA | |
| SCHEMBL629696 | 0.79 | SMN1; SMN2 (0.58) | SMN1; SMN2PRNPDGAT1MPOCYP24A1 | |
| SCHEMBL13477034 | 0.79 | SMN1; SMN2 (0.47) | SMN1; SMN2PRNPDGAT1MPOCYP24A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7432284-B2 | Estrogen receptor modulators | MERCK & CO., INC. (US) | 2008-10-07 | — | — | US | disclosed |
| US-7432284-B2 | Estrogen receptor modulators | MERCK & CO., INC. (US) | 2008-10-07 | — | — | US | disclosed |
| US-7432284-B2 | Estrogen receptor modulators | MERCK & CO., INC. (US) | 2008-10-07 | — | — | US | disclosed |
| US-20060041003-A1 | Estrogen receptor modulators | MERCK SHARP & DOHME LLC | 2006-02-23 | — | — | US | disclosed |
| EP-1551820-A2 | ESTROGEN RECEPTOR MODULATORS | Merck & Co., Inc. (US) | 2005-07-13 | — | — | EP | disclosed |
| WO-2004026887-A2 | ESTROGEN RECEPTOR MODULATORS | MERCK & CO., INC. (US) | 2004-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060041003-A1 | Estrogen receptor modulators | GPER1, ESR2, ESR1 | SMN1; SMN2 1753/4885PRNP 1632/4885DGAT1 912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.